Evidence map›Paper›PMID 41257808›Full record

ReviewBMC women's health2025

Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women's health in the Middle East and Africa.

Bibi Fatima Choonara, Ali Mobasheri, Ahmed Hamdy, Morten Georg Jensen

Abstract readReview
In one paragraph

Review in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bibi Fatima ChoonaraHaleon (formerly GlaxoSmithKline Consumer Healthcare), R&D Innovation & Development, Middle East and Africa, Cape Town, 7460, South Africa. bibifatima.x.choonara@haleon.com.
Ali MobasheriResearch Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, P.O. Box 5000, Oulu, FI-90014, Finland.
Ahmed HamdyHaleon (formerly GlaxoSmithKline Consumer Healthcare), Medical Affairs, Middle East and Africa, United Arab Emirates, Dubai, 23816, United Arab Emirates.
Morten Georg JensenHaleon (formerly GlaxoSmithKline Consumer Healthcare), R&D Innovation & Development, Middle East and Africa, Vallensbaek Strand, 372665, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysmenorrhea, defined by painful menstrual cramps, is a highly prevalent gynecological condition impacting women worldwide. In the Middle East and Africa (MEA) region, its management is particularly challenging due to specific sociocultural barriers and environmental factors like extreme heat conditions. These challenges not only complicate access to effective treatment but also exacerbate the condition's impact on women's daily lives and overall well-being. This narrative review article examines the prevalence of dysmenorrhea in the MEA region, its significant impact on women's quality of life, and the various pharmacological and non-pharmacological approaches that are available for its management. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for dysmenorrhea, but their efficacy is often compromised due to improper storage under high temperatures and humidity, which is an important logistical challenge in the region. Also, improper use may cause adverse effects. Therefore, non-pharmacological treatments such as heat application, exercise, and herbal medicine are gaining recognition for their safety and effectiveness. This article also explores cultural factors that hinder effective treatment, including the stigma surrounding menstruation and public misconceptions about pharmacological options. The review highlights the need for holistic, patient-centered approaches that integrate education, lifestyle modifications, and innovative storage solutions to ensure drug efficacy in the MEA region. Additionally, the role of digital technologies in improving menstrual health management through symptom tracking and patient education is discussed. Addressing both the sociocultural and environmental barriers is crucial to improving dysmenorrhea management and enhancing the quality of life for women in the MEA region.

Indexed as

DysmenorrheaHolistic HealthWomen's HealthAfricaAnti-Inflammatory Agents, Non-SteroidalFemaleHumansMiddle EastQuality of LifeAnti-Inflammatory Agents, Non-SteroidalDysmenorrheaMenstrual healthMiddle East and Africa (MEA)Non-pharmacological treatmentsNonsteroidal anti-inflammatory drugs (NSAIDs)StabilityWomen’s health

Identifiers

PMID41257808
PMCPMC12628934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.